MRV.TO
Nuvo Pharmaceuticals Inc
Price:  
1.35 
CAD
Volume:  
5,500.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRV.TO WACC - Weighted Average Cost of Capital

The WACC of Nuvo Pharmaceuticals Inc (MRV.TO) is 5.5%.

The Cost of Equity of Nuvo Pharmaceuticals Inc (MRV.TO) is 7.60%.
The Cost of Debt of Nuvo Pharmaceuticals Inc (MRV.TO) is 5.40%.

Range Selected
Cost of equity 5.30% - 9.90% 7.60%
Tax rate 2.10% - 5.70% 3.90%
Cost of debt 5.40% - 5.40% 5.40%
WACC 5.3% - 5.7% 5.5%
WACC

MRV.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.42 0.95
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.30% 9.90%
Tax rate 2.10% 5.70%
Debt/Equity ratio 6.33 6.33
Cost of debt 5.40% 5.40%
After-tax WACC 5.3% 5.7%
Selected WACC 5.5%